Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-23-006824

CVP,Strategy/Corp Development sold 3,500 shares at $89.77 ($314,195)

  • CVP,Strategy/Corp Development acquired 3,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BOBO DONALD E JR · CVP,Strategy/Corp Development

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-06-14 Exercise or conversion : show line 1 in the form 10b5-1 +3,500 $36.75 $128,625 43,002.69 D
2023-06-14 Sale : show line 2 in the form 10b5-1 −3,500 $89.77 $314,195 39,502.69 D
Open-market sales · 3,500 sh · avg $89.77 · $314,195

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-06-14 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) −3,500 $36.75 2024-05-10 3,500 79,500 D
Loading xslF345X04/doc4.xml…